Scentian Bio
New Zealand · $7.3M raised
- Business Model
- B2B
- Website
- scentianbio.com
- Total Funding
- $7.3M
- Last Round
- $3.5M Series AJan 2020
- Rounds
- 3
About
Biotech spinout from Plant & Food Research harnessing insect smell receptors for novel biosensor technology.
Summary
Scentian Bio is a Biotech company based in New Zealand. It has raised $7.3M in total across 3 rounds, most recently a $3.5M Series A round in Jan 2020. Investors include Bill & Melinda Gates Foundation, Finistere Ventures and Toyota Ventures.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2020
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company